Stay updated on Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the study record history, and the previous revision (v3.6.6) was removed from the current history view.
    Difference
    0.1%
    Check dated 2026-09-22T12:25:00.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Record history shows the page version updated from v3.6.5 to v3.6.6, indicating an internal revision of the history page. This is an administrative update and does not modify study details.
    Difference
    0.1%
    Check dated 2026-08-31T23:28:19.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 has been added to the study's record history, indicating an update to the trial record. The previous revision v3.6.4 has been removed from the history list.
    Difference
    0.1%
    Check dated 2026-08-10T18:30:47.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The revision entry in the Record History was updated from v3.6.3 to v3.6.4, indicating a newer version of the page's history. This represents an administrative update to the page rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-07-27T06:26:59.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The history gains a new revision entry v3.6.3, replacing the previous v3.6.2. This reflects an update to the record metadata rather than any changes to the study data.
    Difference
    0.1%
    Check dated 2026-07-05T13:26:33.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The revision history now shows a new revision v3.6.2, replacing the previous v3.6.0. This indicates a minor site version update reflected in the study history without altering the study data.
    Difference
    0.1%
    Check dated 2026-06-28T08:13:09.000Z thumbnail image

Stay in the know with updates to Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.